This study aimed to prove that YAP1 plays a tumor‐promoting role in Hp‐induced gastric carcinogenesis via activating the key cancer‐related inflammatory cytokine IL‐1β and thereby provide a new drug target for GC treatment. This evidence concerns the gene YAP1 and cancer.